DEX-MOXI-KETOR Trademark

Trademark Overview

On Monday, February 27, 2017, a trademark application was filed for DEX-MOXI-KETOR with the United States Patent and Trademark Office. The USPTO has given the DEX-MOXI-KETOR trademark a serial number of 87351119. The federal status of this trademark filing is CANCELLATION PENDING as of Tuesday, October 7, 2025. This trademark is owned by IMPRIMIS PHARMACEUTICALS, INC.. The DEX-MOXI-KETOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions for ophthalmological use
dex-moxi-ketor

General Information

Serial Number87351119
Word MarkDEX-MOXI-KETOR
Filing DateMonday, February 27, 2017
Status790 - CANCELLATION PENDING
Status DateTuesday, October 7, 2025
Registration Number5587077
Registration DateTuesday, October 16, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2017

Trademark Statements

Goods and ServicesPharmaceutical compositions for ophthalmological use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 6, 2017
Primary Code005
First Use Anywhere DateWednesday, February 1, 2017
First Use In Commerce DateWednesday, February 1, 2017

Trademark Owner History

Party NameHARROW IP, LLC
Party Type32 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressNashville, TN 37205
Party NameHARROW HEALTH, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92130
Party NameIMPRIMIS PHARMACEUTICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameIMPRIMIS PHARMACEUTICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameIMPRIMIS PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Thursday, March 2, 2017NEW APPLICATION ENTERED
Monday, March 6, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 3, 2017ASSIGNED TO EXAMINER
Monday, May 8, 2017PRIORITY ACTION WRITTEN
Monday, May 8, 2017PRIORITY ACTION E-MAILED
Monday, May 8, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, October 19, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 30, 2017ASSIGNED TO LIE
Wednesday, November 1, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 1, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 3, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2017PUBLISHED FOR OPPOSITION
Tuesday, December 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 6, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 31, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, August 28, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 31, 2018USE AMENDMENT FILED
Tuesday, August 28, 2018STATEMENT OF USE PROCESSING COMPLETE
Friday, September 7, 2018ASSIGNED TO EXAMINER
Friday, September 7, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, September 8, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 16, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, January 16, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, November 6, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, November 27, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, September 14, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, September 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 14, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, September 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 14, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 16, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, December 16, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 16, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 16, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 16, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 12, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, October 16, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 15, 2024TEAS SECTION 8 & 15 RECEIVED
Friday, February 21, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, February 21, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, February 21, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, October 7, 2025CANCELLATION INSTITUTED NO. 999999
Wednesday, October 29, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Related Keywords

ketor moxi ophthalmological compositions pharmaceutical